Tabuchi Y, Nakamura T, Kuniyasu T, Ohno M, Nakae S
Faculty of Health Science, Kobe University School of Medicine, Japan.
Surg Today. 1999;29(2):116-20. doi: 10.1007/BF02482235.
The correlations of nm23-H1 expression in primary cancer lesions with the already confirmed 14 prognostic variables and survival were examined in 52 advanced colorectal cancer patients, because the clinical roles of nm23-H1 expression in the cancer lesions remain controversial. An immunohistochemical expression of nm23-H1 was found in 23 lesions (positive group) but not found in 29 lesions (negative group). No significant difference between the positive and negative groups was found according to 12 clinicopathological variables including vascular invasion, lymph node and liver metastases, and histological stage. The carcinoembryonic antigen levels (21.5+/-33.4 ng/ml) of the draining venous blood and argyrophilic nucleolar organizer regions score (3.35+/-1.36 per nucleus) of the cancer cells in the positive group were not significantly diffeent from those (34.1+/-102.9 ng/ml and 3.32+/-1.00 per nucleus, respectively) in the negative group. In addition, no significant difference was found in the survival curves or the 5-year survival rates of the positive and negative groups. From these results, it may be concluded that the nm23-H1 expression was not associated with the aforementioned prognostic variables and the prognosis of advanced colorectal cancer patients.
由于nm23-H1在癌灶中的临床作用仍存在争议,因此在52例晚期结直肠癌患者中研究了原发癌灶中nm23-H1表达与已确认的14个预后变量及生存率之间的相关性。在23个病灶中发现nm23-H1的免疫组化表达(阳性组),而在29个病灶中未发现(阴性组)。根据包括血管侵犯、淋巴结和肝转移以及组织学分期在内的12个临床病理变量,阳性组和阴性组之间未发现显著差异。阳性组引流静脉血的癌胚抗原水平(21.5±33.4 ng/ml)和癌细胞的嗜银核仁组成区评分(每个细胞核3.35±1.36)与阴性组(分别为34.1±102.9 ng/ml和每个细胞核3.32±1.00)相比无显著差异。此外,阳性组和阴性组的生存曲线或5年生存率也未发现显著差异。从这些结果可以得出结论,nm23-H1表达与上述预后变量及晚期结直肠癌患者的预后无关。